Please login to the form below

Not currently logged in
Email:
Password:

global access

This page shows the latest global access news and features for those working in and with pharma, biotech and healthcare.

Novartis first to benefit from NICE advice on ‘patient preference’

Novartis first to benefit from NICE advice on ‘patient preference’

Nigel Cook, Head of Decision Support &Insights, Global Patient Access at Novartis said:  “The scientific advice provided by NICE, together with the patient representative and other external experts, has been very

Latest news

  • Novartis aims for 10 blockbuster launches by 2020 Novartis aims for 10 blockbuster launches by 2020

    The company is also expanding its global manufacturing capacity, which should allow it to compete with its rival, Gilead’s Yescarta, which has established a lead in the nascent market. ... Vas Narasimhan commented: "In 2018 we reimagined Novartis. We

  • D-day: time to make digital deliver D-day: time to make digital deliver

    One of the biggest opportunities, says Aaron Bean, will likely emerge through ‘industry platforms’ where stakeholders from across the ecosystem can access, contribute to and share relevant data. ... Digital D-day. There’s little doubt that digital

  • Despite FDA concerns, Akcea rare disease drug clears FDA panel Despite FDA concerns, Akcea rare disease drug clears FDA panel

    Earlier this week, Akcea, a subsidiary of Ionis, announced that it would be expanding its global early access programme (EAP) for volanesorsen to the US.

  • Pfizer takes aim at UK’s health tech industry Pfizer takes aim at UK’s health tech industry

    The successful start-ups will benefit from access to Pfizer’s network of global partners, including the NHS. ... Dr Hamish Graham, manager for Pfizer Healthcare Hub: London, said: “The healthcare hub will provide a platform for start-ups to harness

  • Alex Butler and Matt Baker launch Foundry3 Alex Butler and Matt Baker launch Foundry3

    Before moving agency-side in 2011, he spent more than a decade within pharma, including six years at J&J in various market access, marketing, communications and digital strategy roles. ... Blackmore said: “Being part of bmore means Foundry. 3. can

More from news
Approximately 0 fully matching, plus 80 partially matching documents found.

Latest Intelligence

  • Shaping healthcare Shaping healthcare

    For Lars the change is newer still as he only moved from Berlin to Reading in September 2017, swapping his role as head of global market access at Bayer Pharma for ... From the perspective of your previous global market access role, in which country did

  • Patient recruitment and engagement standards Patient recruitment and engagement standards

    They were gathering as much data as possible - global, local, whatever they have access to, to predict what their clinical trial process would look like. ... We all agreed that such platforms are invaluable for:. Granting better access to patients.

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    Furthermore, not all of these technologies would necessarily complete the Accelerated Access Pathway. ... is an independent global market access consultant. 18th January 2017.

  • Going fully digital Going fully digital

    For instance, 85% of respondents said they lack the ability to report on content status and process bottlenecks, while 75% reported missing global digital asset management (DAM) systems. ... And because the content management solution is in the cloud,

  • Tracking comms trends: 2 + 2 = 7: bad maths, or good sense? Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

    From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today.

More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.

Latest appointments

  • Greg Perry joins IFPMA as assistant director general Greg Perry joins IFPMA as assistant director general

    Perry, who was most recently executive director of the Medicines Patent Pool in Geneva, will move to the global industry body in February. ... At the IFPMA he will have responsibility for its external outreach and stakeholder engagement on global health

  • Bayer UK and Ireland appoints new CEO Bayer UK and Ireland appoints new CEO

    was head of the pharma group’s global market access business. ... Prior to that Bruening held senior commercial roles in Europe, the Middle East and Asia, bringing knowledge in the pharmaceutical sector, international healthcare landscape and global

  • Ashfield appoints new leaders in the US and Japan Ashfield appoints new leaders in the US and Japan

    in a role that will see him deliver commercial, clinical, pharmacovigilance and market access operations. ... Tompkins added: “ The appointment of Mick O’Leary as regional president in Japan will continue our success story and excellent results in

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... Wheatley Price joins Takeda from GlaxoSmithKline, where he

  • GalbraithWight appoints Eithne McShane and Steve Mazzarese GalbraithWight appoints Eithne McShane and Steve Mazzarese

    They join the market access consultancy as global business development directors. ... In her new role at UK-based market access consultancy she will be tasked with growing GalbraithWight's business with global and regional clients located in Europe.

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • GCI Health hires Kim Walker as Deputy Managing Director in London

    Commenting on Kim’s appointment Kath said: “As a fast-growing global agency, delivering above and beyond client expectations, it is essential that we have the right leaders to contribute to ... environment. With a deep focus on multi-channel marketing

  • Market Access Transformation

    available. Rapid Payer Response specializes in creating new technologies that allow pharmaceutical companies and manufacturers get feedback and insight on demand from a network of global, expert payers. ... Board Vice Chairman. View LinkedIn profile.

  • Curo

    We are a global Pharma Market Access consultancy, with the core belief in adopting a collaborative approach to Payer engagement.

  • Valid Insight

    Valid Insight is a specialist global market access consultancy. With a team that includes some of the world’s leading market access and pricing experts, our clients trust us to help ... We focus on pricing, market access and value communication

  • Medical Media Communications

    MMC Scientific is the dedicated medical communications agency of The Radcliffe Group Ltd, affiliated to Radcliffe Cardiology, granting access to its global database of 65, 000+ cardiologists worldwide.

More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics